用于治疗脓毒症和脓毒性休克的抗炎疗法：重新评估 - Suppr

Suppr

超能文献

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.

作者信息

Zeni F, Freeman B, Natanson C

出版信息

Crit Care Med. 1997 Jul;25(7):1095-100. doi: 10.1097/00003246-199707000-00001.

DOI:10.1097/00003246-199707000-00001

PMID:9233726

Abstract

摘要

相似文献

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.

Crit Care Med. 1997 Jul;25(7):1095-100. doi: 10.1097/00003246-199707000-00001.

Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

Crit Care Med. 1997 Jul;25(7):1115-24. doi: 10.1097/00003246-199707000-00010.

Sepsis therapy trials. Continued disappointment or reason for hope?

JAMA. 1994 Jun 15;271(23):1876-8. doi: 10.1001/jama.271.23.1876.

Effects of recombinant interleukin-1-receptor antagonist.

Am J Hosp Pharm. 1994 May 1;51(9):1253, 1257.

Alternative views on the effects of recombinant interleukin-1-receptor antagonist.

Am J Hosp Pharm. 1994 Nov 1;51(21):2724-7.

From the Food and Drug Administration.

JAMA. 2002 Jan 2;287(1):33.

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.

JAMA. 1994 Jun 15;271(23):1836-43.

Interleukin-1 receptor antagonist as therapy for inflammatory disorders.

Expert Opin Biol Ther. 2001 Mar;1(2):301-8. doi: 10.1517/14712598.1.2.301.

Glucocorticoid administration in sepsis and septic shock: time for a paradigm change?

Minerva Anestesiol. 2014 Sep;80(9):1058-62. Epub 2014 Jun 27.

Defining sepsis.

JAMA. 1994 Dec 28;272(24):1901.

引用本文的文献

Microarray Analysis Reveals Sepsis Is a Syndrome with Hyperactivity of TH17 Immunity, with Over-Presentation of the Treg Cell Cytokine TGF-β.

Curr Issues Mol Biol. 2025 Jun 9;47(6):435. doi: 10.3390/cimb47060435.

Sepsis: the evolution of molecular pathogenesis concepts and clinical management.

MedComm (2020). 2025 Feb 23;6(3):e70109. doi: 10.1002/mco2.70109. eCollection 2025 Mar.

Thromboelastometry-Based Profiling of Haemostatic Alterations in Neonatal Sepsis by Causative Pathogens.

Antibiotics (Basel). 2025 Jan 17;14(1):101. doi: 10.3390/antibiotics14010101.

Gut lymph purification alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats by removing danger-associated molecular patterns from gut lymph.

Heliyon. 2024 Feb 2;10(3):e25711. doi: 10.1016/j.heliyon.2024.e25711. eCollection 2024 Feb 15.

Exploring the biomarkers and potential therapeutic drugs for sepsis via integrated bioinformatic analysis.

BMC Infect Dis. 2024 Jan 2;24(1):32. doi: 10.1186/s12879-023-08883-9.

Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options.

Chin J Traumatol. 2024 Mar;27(2):63-70. doi: 10.1016/j.cjtee.2023.11.001. Epub 2023 Nov 8.

Bioinspired copper single-atom nanozyme as a superoxide dismutase-like antioxidant for sepsis treatment.

Exploration (Beijing). 2022 Jul 13;2(4):20210267. doi: 10.1002/EXP.20210267. eCollection 2022 Aug.

Potential therapeutic effect of leaves extract on immune response, biochemical and hematological mechanisms on cecal ligation and puncture model of sepsis in rats: an in vivo study.

3 Biotech. 2023 May;13(5):151. doi: 10.1007/s13205-023-03567-2. Epub 2023 Apr 29.

Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression.

Mil Med Res. 2022 Dec 26;9(1):74. doi: 10.1186/s40779-022-00430-y.

Publication trends of research on sepsis and programmed cell death during 2002-2022: A 20-year bibliometric analysis.

Front Cell Infect Microbiol. 2022 Sep 23;12:999569. doi: 10.3389/fcimb.2022.999569. eCollection 2022.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验